NCT00725036 - Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes | Biotech Hunter

Enrollment

305

Participants

Timeline

Start Date

September 2, 2002

Primary Completion Date

December 14, 2004

Study Completion Date

December 14, 2004

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

inhaled human insulin

DRUG

insulin aspart

DRUG

insulin NPH

Trial Locations (18)

2031

Novo Nordisk Investigational Site, Randwick

2050

Novo Nordisk Investigational Site, Camperdown

2065

Novo Nordisk Investigational Site, St Leonards

2292

Novo Nordisk Investigational Site, Broadmeadow

2500

Novo Nordisk Investigational Site, Wollongong

2605

Novo Nordisk Investigational Site, Garran

3050

Novo Nordisk Investigational Site, Parkville

3085

Novo Nordisk Investigational Site, Heidelberg

3128

Novo Nordisk Investigational Site, Box Hill

3168

Novo Nordisk Investigational Site, Clayton

4102

Novo Nordisk Investigational Site, Woolloongabba

4120

Novo Nordisk Investigational Site, Stones Corner

5035

Novo Nordisk Investigational Site, Keswick

Novo Nordisk Investigational Site, Ashford

6000

Novo Nordisk Investigational Site, Perth

6160

Novo Nordisk Investigational Site, Fremantle

Unknown

Novo Nordisk Investigational Site, Auckland

Novo Nordisk Investigational Site, Christchurch